VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $710,532 | +95018.1% | 26,404 | +6.4% | 0.16% | -3.7% |
| Q2 2023 | $747 | -8.5% | 24,816 | 0.0% | 0.16% | -5.2% |
| Q1 2023 | $816 | +10.6% | 24,816 | -3.6% | 0.17% | +3.0% |
| Q4 2022 | $738 | -99.9% | 25,747 | -0.3% | 0.17% | +13.6% |
| Q3 2022 | $635,000 | -49.4% | 25,816 | -44.4% | 0.15% | -48.1% |
| Q2 2022 | $1,255,000 | -32.2% | 46,403 | -3.8% | 0.28% | -20.3% |
| Q1 2022 | $1,850,000 | +20.6% | 48,237 | -1.0% | 0.36% | +20.7% |
| Q4 2021 | $1,534,000 | +0.3% | 48,737 | -6.1% | 0.29% | +2.4% |
| Q3 2021 | $1,529,000 | -14.8% | 51,900 | -1.9% | 0.29% | -25.5% |
| Q2 2021 | $1,795,000 | +2.1% | 52,900 | +0.4% | 0.38% | +0.8% |
| Q1 2021 | $1,758,000 | -12.3% | 52,700 | +0.3% | 0.38% | -17.8% |
| Q4 2020 | $2,005,000 | -2.5% | 52,550 | -0.4% | 0.46% | -22.5% |
| Q3 2020 | $2,057,000 | -6.4% | 52,750 | -7.6% | 0.60% | -7.4% |
| Q2 2020 | $2,197,000 | – | 57,100 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |